SILO PHARMA, INC. Legal Fees
SILO PHARMA, INC. (SILO) had Legal Fees of $50.00 thousand as of 2024-07-31, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2025-11-13
- 2024-07-31: Legal Fees $50.00K.
- 2024-07-22: Legal Fees $89.03K.
- 2024-07-18: Legal Fees $89.03K.
- 2024-06-30: Legal Fees 6 month $65.83K.
| Period end | Legal Fees | Legal Fees 1 month | Legal Fees 6 month |
|---|---|---|---|
| 2024-07-31 | $50.00K 10-Q · filed 2025-11-13 | ||
| 2024-07-22 | $89.03K 10-Q · filed 2025-05-09 | ||
| 2024-07-18 | $89.03K 10-K · filed 2025-03-28 | ||
| 2024-06-30 | $65.83K 10-Q · filed 2024-08-13 | ||
| 2022-10-25 | $41.31K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |